SerpinB9 expression in human renal tubular epithelial cells is induced by triggering of the viral dsRNA sensors TLR3, MDA5 and RIG-I

Nephrology Dialysis Transplantation

Volumn 27, Issue 7, 2012, Pages 2746-2754

  Heutinck, Kirstin M ^a,b   Kassies, Jorien ^a   Florquin, Sandrine ^c   Ten Berge, Ineke J M ^b   Hamann, Jörg ^a   Rowshani, Ajda T ^b,d  

^a Division of Nephrology   (Netherlands)

^b Renal Transplant Unit   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

dsRNA receptors; kidney transplantation; PI 9; serpins; viral infection

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; DOUBLE STRANDED RNA; GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MEMBRANE PROTEIN; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RETINOIC ACID INDUCIBLE PROTEIN I; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR B9; TACROLIMUS; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TUBULE; KIDNEY TUBULE CELL; LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; UPREGULATION;

BIOPSY; BK VIRUS; BLOTTING, WESTERN; CELLS, CULTURED; DEAD-BOX RNA HELICASES; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LYMPHOCYTES; POLY I-C; POLYOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, DOUBLE-STRANDED; RNA, MESSENGER; RNA, VIRAL; SERPINS; TOLL-LIKE RECEPTOR 3; TUMOR VIRUS INFECTIONS;

EID: 84861011695     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr690     Document Type: Article

References (54)

1. Whisstock JC, Bottomley SP. Molecular gymnastics: serpin structure, folding and misfolding. Curr Opin Struct Biol 2006; 16: 761-768.
2. Kaiserman D, Bird PI. Control of granzymes by serpins. Cell Death Differ 2010; 17: 586-595.
3. Izuhara K, Ohta S, Kanaji S et al. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family. Cell Mol Life Sci 2008; 65: 2541-2553.
4. Hirst CE, Buzza MS, Bird CH et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol 2003; 170: 805-815.
5. Bots M, van Bostelen L, Rademaker MTet al. Serpins prevent granzyme-induced death in a species-specific manner. Immunol Cell Biol 2006; 84: 79-86.
6. Cunningham TD, Jiang X, Shapiro DJ. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. Cell Immunol 2007; 245: 32-41.
7. Heutinck KM, ten Berge IJM, Hack CE et al. Serine proteases of the human immune system in health and disease. Mol Immunol 2010; 47: 1943-1955.
8. Bots M, de Bruin E, Rademaker-Koot MT et al. Proteinase inhibitor-9 expression is induced by maturation in dendritic cells via p.38 MAP kinase. Hum Immunol 2007; 68: 959-964.
9. Rowshani AT, Florquin S, Bemelman F et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int 2004; 66: 1417-1422.
10. Buzza MS, Hirst CE, Bird CH et al. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol 2001; 210: 21-29.
11. Bladergroen BA, Strik MC, Bovenschen N et al. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol 2001; 166: 3218-3225.
12. Bladergroen BA, Strik MC, Wolbink AM et al. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells. Eur J Immunol 2005; 35: 1175-1183.
13. Medema JP, Schuurhuis DH, Rea D et al. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med 2001; 194: 657-667.
14. Stout-Delgado HW, Getachew Y, Rogers TE et al. The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity. Hepatology 2007; 46: 1530-1540.
15. van Houdt I, Oudejans JJ, van den Eertwegh AJ et al. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma. Clin Cancer Res 2005; 11: 6400-6407.
16. Jiang X, Ellison SJ, Alarid ET et al. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 2007; 26: 4106-4114.
17. Andrew KA, Simkins HM, Witzel S et al. Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. J Immunol 2008; 181: 8356-8362.
18. Godal R, Keilholz U, Uharek L et al. Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2. Blood 2006; 107: 3205-3211.
19. van Kooten C, Daha MR. Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cells. Curr Opin Nephrol Hypertens 2001; 10: 55-59.
20. Choy JC, Hung VH, Hunter AL et al. Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation. Arterioscler Thromb Vasc Biol 2004; 24: 2245-2250.
21. Zhang ZX, Wang S, Huang X et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008; 181: 7489-7498.
22. Van Oers MH, Van der Heyden AA, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 314-319.
23. Raasveld MH, Bloemena E, Wilmink JM et al. Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study. Transpl Int 1993; 6: 89-94.
24. Raasveld MH, Weening JJ, Kerst JM et al. Local production of interleukin-6 during acute rejection in human renal allografts. Nephrol Dial Transplant 1993; 8: 75-78.
25. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
26. Alegre ML, Leemans J, Le MA et al. The multiple facets of Tolllike receptors in transplantation biology. Transplantation 2008; 86: 1-9.
27. Kummer JA, Wever PC, Kamp AM et al. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70-77.
28. Kannan-Thulasiraman P, Shapiro DJ. Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J Biol Chem 2002; 277: 41230-41239.
29. Classen CF, Bird PI, Debatin KM. Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection. Clin Exp Immunol 2006; 143: 534-542.
30. Barrie MB, Stout HW, Abougergi MS et al. Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6. J Immunol 2004; 172: 6453-6459.
31. Horie O, Saigo K, Murayama T et al. Differential expression of proteinase inhibitor-9 and granzyme B mRNAs in activated immunocompetent cells. Tohoku J Exp Med 2005; 205: 103-113.
32. van Kooten C, Lam S, Daha MR. Isolation, culture, characterization and use of human renal tubular epithelial cells. J Nephrol 2001; 14: 204-210.
33. Bots M, Medema JP. Serpins in T cell immunity. J Leukoc Biol 2008; 84: 1238-1247.
34. Gillard A, Scarff K, Loveland KL et al. Modulation and redistribution of proteinase inhibitor 8 (Serpinb8) during kidney regeneration. Am J Nephrol 2006; 26: 34-42.
35. Imaizumi T, Tanaka H, Matsumiya T et al. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrol Dial Transplant 2010; 25: 3534-3539.
36. Kariko K, Ni H, Capodici J et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-12550.
37. Yoneyama M, Fujita T. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 2010; 20: 4-22.
38. Hirst CE, Buzza MS, Sutton VR et al. Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol Hum Reprod 2001; 7: 1133-1142.
39. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
40. Weikert BC, Blumberg EA. Viral infection after renal transplantation: surveillance and management. Clin J Am Soc Nephrol 2008; 3Suppl 2S76-S86.
41. Heieren MH, Kim YK, Balfour HH, Jr. Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation 1988; 46: 426-432.
42. Becker JL, Miller F, Nuovo GJ et al. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest 1999; 104: 1673-1681.
43. Low J, Humes HD, Szczypka M et al. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004; 323: 182-188.
44. Sun J, Bird CH, Sutton V et al. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem 1996; 271: 27802-27809.
45. Rowshani AT, Strik MC, Molenaar R et al. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J Infect Dis 2005; 192: 1908-1911.
46. Dadhania D, Snopkowski C, Ding R et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010; 90: 189-197.
47. Iwakiri D, Zhou L, Samanta M et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J Exp Med 2009; 206: 2091-2099.
48. Samanta M, Iwakiri D, Kanda T et al. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006; 25: 4207-4214.
49. Yajima M, Kanda T, Takada K. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J Virol 2005; 79: 4298-4307.
50. Vilaysane A, Muruve DA. The innate immune response to DNA. Semin Immunol 2009; 21: 208-214.
51. Bowie AG, Unterholzner L. Viral evasion and subversion of patternrecognition receptor signalling. Nat Rev Immunol 2008; 8: 911-922.
52. Lai Y, Di NA, Nakatsuji T et al. Commensal bacteria regulate Tolllike receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15: 1377-1382.
53. Perrot I, Deauvieau F, Massacrier C et al. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-{gamma{in response to double-stranded RNA. J Immunol 2010; 185: 2080-2088.
54. Goubau D, Romieu-Mourez R, Solis M et al. Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. Eur J Immunol 2009; 39: 527-540.